ENTA · ISSUER CIK 1177648
ENANTA PHARMACEUTICALS INC
Between Aug 1, 2026 and Oct 29, 2026, 1 ENANTA PHARMACEUTICALS INC insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 10, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 202609:00 | Aug 8, 2026 | ENTA | Chief Medical Officer | F · Tax | $13.34 | −1,467 | 23,787 | -6% | $20K |